Clindamycin phosphate in dextrose 5%?

Clindamycin phosphate in 5 % dextrose (IV/IM) is a ready‑to‑inject formulation of the antibiotic clindamycin. Below is a concise “drug overview” that covers why it’s used, how it’s given, what to watch for, and key patient counseling points.

---

What is it?

Item	Details
Active ingredient	Clindamycin phosphate (a prodrug that is rapidly converted to clindamycin)
Diluent	5 % dextrose in water (D5W) – a sugar solution that also helps maintain isotonicity.
Common brands	CLC 20 (Baxter), Clindoxyl (Teva), and others depending on region.
Form	Vial for IV push or IM injection; often reconstituted before use.
Mechanism of action	Binds to the 50S ribosomal subunit → inhibits protein synthesis → bacteriostatic (can become bactericidal at high concentrations).

---

Indications (what it’s used for)

• Acute bacterial skin & skin‑structure infections (e.g., cellulitis, abscesses)
• Infections of the oral, maxillofacial, and dental areas (e.g., post‑operative or odontogenic abscesses)
• Bacterial infections of the respiratory tract (e.g., aspiration pneumonia)
• Complicated intra‑abdominal infections (often in combination with other antibiotics)
• Bone & joint infections (often combined with other agents)
• Gynecologic infections (e.g., pelvic inflammatory disease)
• Certain intra‑abdominal or pelvic infections in patients allergic to penicillin

It’s a broad‑spectrum antibiotic that covers many gram‑positive cocci (including MRSA) and anaerobes.

---

Typical adult dosing (examples – your clinician will decide the exact amount)

Route	Typical dose	Frequency	Note
IV push	600 mg (or 600 mg/12 ml)	Every 8 h	Can be given over 15–30 min.
IV infusion	600 mg	Every 8 h	For patients who cannot tolerate IV push.
IM	600 mg	Every 8 h	Usually not the first choice in serious infections.

The total daily dose usually ranges from 1,200 mg to 2,400 mg, depending on infection severity, site, and patient factors (e.g., renal function).

---

How it’s administered

1. Reconstitution

   • Shake the vial gently.
   • Add the required amount of 5 % dextrose (or pre‑filled solution).
   • Mix until clear; avoid vigorous shaking to preserve the drug.

2. IV push

   • Use a 3–5 mm infusion set or a syringe.
   • Push slowly over 15–30 min; monitor for infusion reactions.

3. IV infusion (if prolonged)

   • Dilute in 250–500 ml of normal saline or D5W.
   • Infuse at the prescribed rate (typically 0.5–2 ml/min).

4. IM

   • Use a 25‑gauge needle.
   • Inject into a large muscle (vastus lateralis or deltoid).
   • Rotate sites to avoid irritation.

---

Pharmacokinetics (quick facts)

• Absorption: IV – 100 % bioavailability. IM – ~60–70 % (variable).
• Distribution: Widely distributed; good penetration into bone, abscesses, and intra‑ocular fluid.
• Protein binding: ~30 % (moderate).
• Metabolism: Minimal hepatic metabolism; largely excreted unchanged.
• Half‑life: ~2.5–3 h (IV/IM); can be prolonged in renal impairment.
• Renal excretion: ~80 % in urine; dose adjustment needed for CrCl < 30 ml/min.

---

Common side effects

Symptom	Frequency	What to do
Diarrhea (often mild)	~10 %	Keep hydrated; report severe or persistent diarrhea.
C. difficile colitis	Rare (but serious)	Seek medical attention if foul‑smelling, watery stools.
Nausea/vomiting	≤ 5 %	Take with food if tolerated; contact clinician if persistent.
Headache	≤ 5 %	OTC analgesics may help; discuss with provider if severe.
Injection‑site reaction (pain, redness)	~2 %	Rotate sites; use proper technique.
Hypersensitivity rash	Rare	Stop drug, seek medical help.

Key warning: Clindamycin can increase the risk of Clostridioides difficile infection, especially when used for prolonged periods or with other antibiotics.

---

Contraindications & cautions

Condition	Recommendation
Known hypersensitivity to clindamycin, lincomycin, or other lincosamides	Avoid.
Severe hepatic impairment	Use with caution; monitor liver function.
Renal dysfunction	Adjust dose; monitor serum levels if possible.
Pregnancy & lactation	Category C; use only if benefits outweigh risks.
Patients on concurrent drugs that prolong QT	Monitor ECG; clindamycin can mildly prolong QT.
Patients with a history of C. difficile colitis	Avoid if possible.

---

Drug interactions

Drug	Interaction	How it manifests
Ketoconazole	Increases clindamycin exposure	↑ risk of adverse effects
Aminoglycosides (e.g., gentamicin)	Additive nephrotoxicity	Monitor renal function
Antacids or H₂ blockers	No major effect on clindamycin	(Unlike some other antibiotics)
Other antibiotics (e.g., β‑lactams)	Potential for synergistic bactericidal activity	Often used together in serious infections
Caffeine	Mild interaction	Not clinically significant

Tip: Always review all current medications (prescription, OTC, supplements) before starting clindamycin.

---

What patients should know

1. Finish the full course – Even if you feel better, stopping early can lead to relapse and resistance.
2. Watch for diarrhea – Especially foul‑smelling or blood‑tinged stools; report immediately.
3. Take with food (if you have GI discomfort) – Helps reduce nausea.
4. Hydrate well – Especially if you’re on a high‑dose or prolonged therapy.
5. Avoid alcohol – Not a strict contraindication, but can worsen GI upset.
6. Notify your clinician if you develop a rash, itching, swelling of lips/face/ throat, or shortness of breath – signs of hypersensitivity.
7. If pregnant or breastfeeding – Discuss risks and benefits with your provider.
8. Keep a record of any other antibiotics or medications you’re taking to prevent interactions.

---

Storage & handling

• Temperature: Store at 2–8 °C (refrigerated).
• Light: Protect from excessive light.
• Shelf life: Check the vial’s expiration date; do not use after expiration.
• Reconstitution: Use the prescribed volume of 5 % dextrose; discard any unused reconstituted solution after 24 h (unless specified by manufacturer).
• Safety: Treat as a hazardous drug; wear gloves and eye protection during preparation.

---

Quick reference summary